Possible Turnaround For Shanghai Junshi Biosciences Insiders, Still Down CN¥4.6m

Simply Wall St.07-05

Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) stock in the last year recovered part of their losses as the stock rose by 23% last week. However, total losses ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2649690608?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-07-05 09:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649690608","market":"sg","top_or_hot":-1,"title":"Possible Turnaround For Shanghai Junshi Biosciences Insiders, Still Down CN¥4.6m","media":"Simply Wall St.","content":"<div>\n<p>Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) stock in the last year recovered part of their losses as the stock rose by 23% last week.  However, total losses ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Possible Turnaround For Shanghai Junshi Biosciences Insiders, Still Down CN¥4.6m</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPossible Turnaround For Shanghai Junshi Biosciences Insiders, Still Down CN¥4.6m\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-05 09:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) stock in the last year recovered part of their losses as the stock rose by 23% last week.  However, total losses ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders","article_id":"2649690608","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2649690608","pubTimestamp":1783215847,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. ( HKG:1877 ) stock in the last year...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","CN":"Xtrackers MSCI All China Equity ETF","01877":"君实生物","BK1583":"高瓴概念","BK1515":"抗疫概念"},"translate_title":"上海君实生物科技内部人士可能扭亏为盈，但仍下跌460万元人民币","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CN":1.5,"01877":1},"content_text":"Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) stock in the last year recovered part of their losses as the stock rose by 23% last week.  However, total losses seen by insiders are still CN¥4.6m since the time of purchase.     Although we don't think shareholders should simply follow insider transactions,  we would consider it foolish to ignore insider transactions altogether.  Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.Advertisement Shanghai Junshi Biosciences Insider Transactions Over The Last Year   In the last twelve months, the biggest single purchase by an insider was when Executive Chairman Jun Xiong bought HK$21m worth of shares at a price of HK$23.92 per share.    That means that an insider was happy to buy shares at above the current price of HK$18.83.  While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future.  In our view, the price an insider pays for shares is very important.   Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.  Jun Xiong was the only individual insider to buy shares in the last twelve months.       You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below.  If you want to know exactly who sold, for how much, and when, simply click on the graph below!  Check out our latest analysis for Shanghai Junshi Biosciences SEHK:1877 Insider Trading Volume July 5th 2026 There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).   Insider Ownership Of Shanghai Junshi Biosciences  Many investors like to check how much of a company is owned by insiders.  A high insider ownership often makes company leadership more mindful of shareholder interests.   Shanghai Junshi Biosciences insiders own about HK$6.1b worth of shares (which is 16% of the company).  Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.   So What Do The Shanghai Junshi Biosciences Insider Transactions Indicate?  There haven't been any insider transactions in the last three months -- that doesn't mean much.    However, our analysis of transactions over the last year is heartening.   It would be great to see more insider buying, but overall it seems like Shanghai Junshi Biosciences insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future.      So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company.    While conducting our analysis, we found that Shanghai Junshi Biosciences has 1 warning sign and it would be unwise to ignore this.   But note: Shanghai Junshi Biosciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2649690608","isCrawlerRequest":true}